Gabapentin Capsule
Product Images NDC 60687-591
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 60687-591). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Ahp58001
Ahp59101
Ahp60201
Cockcroft And Gault Equation (Equation)
This appears to be a formula for calculating creatinine clearance (CLCr), which is an estimate of renal function. The calculation requires the patient's age (in years), weight (in kilograms), and serum creatinine (in milligrams per deciliter). The formula also includes an adjustment factor of 0.85 for female patients. If CLCr cannot be calculated accurately, other methods may be used to estimate renal function.*
Figure 1. Weekly Mean Pain Scores (observed Cases In Itt Population): Study 1 (Figure1)
This is a data table showing the mean pain score for patients undergoing a dose titration period followed by a fixed dose period. The data compares the effectiveness of gabapentin at 3600mg/day versus a placebo. The mean pain score is scored on a scale of 1 to 10. There is no other information available.*
Figure 2. Weekly Mean Pain Scores (observed Cases In Itt Population): Study 2 (Figure2)
Figure 3. Proportion Of Responders (patients With ≥ 50% Reduction In Pain Score) At Endpoint: Controlled Phn Studies (Figure3)
The text represents a figure showing the percentage of responders in controlled studies for Postherpetic Neuralgia (PHN). The studies involved patients who experienced at least 50% reduction in pain score. The figure includes two studies, and each study had a different treatment (GBP 3600, GBP 1800, GBP 2400, and PBO) with varying response rates, ranging from 0% to 90%.*
Figure 4. Responder Rate In Patients Receiving Gabapentin Expressed As A Difference From Placebo By Dose And Study: Adjunctive Therapy Studies In Patients ≥ 12 Years Of Age With Partial Seizures (Figure4)
Structural Formula (Structure)
Image 01
This is a description of a medication called Gabapentin. It is in capsule form and there are 100 capsules per package. Each capsule contains 100mg of Gabapentin USP. The dosage can be found in the package insert. The medication should be stored at room temperature, kept away from children, and must not be used after the expiration date. It is distributed by American Health Packaging in Ohio.*
Image 03
This is a description of a medication for use with patients. It is Gabapentin, which is contained in a USP capsule. There are 100 capsules in total contained within the package, with 10 capsules per packet. The packaging contains a medication guide that must be given to the patient. The medication itself is manufactured by N 67577-225, Ascend Laboratories, LLC. The distribution of the medication is handled by American Health Packaging, based in Columbus, OH. The packaging also contains dosage information as well as storage instructions, including temperature and storage recommendations.*
Image 04
Image 05
This is a bottle of Gabapentin Capsules USP containing 100 capsules. The pack is RX only, and each capsule contains Gabapentin USP 100mg. The usual dosage is given in the package insert. Store between 20° to 25°C, and keep out of reach of children. The drug product distributed by American Health Packaging in Columbus, Ohio 43217. NDC 60687-602-01 is mentioned multiple times in the text.*
Image 06
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.